- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 126,306,466
- Share change
- +928,309
- Total reported value
- $35,966,219,806
- Put/Call ratio
- 109%
- Price per share
- $284.85
- Number of holders
- 994
- Value change
- +$277,366,431
- Number of buys
- 398
- Number of sells
- 447
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
16,001,166
|
$4,448,804,183 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.5%
|
13,986,221
|
$3,888,589,023 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
12,157,662
|
$3,380,194,766 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
6,757,000
|
$1,878,641,414 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.7%
|
5,452,888
|
$1,516,066,450 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.8%
|
4,108,863
|
$1,142,385,901 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
3,102,735
|
$860,775,144 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
2,088,356
|
$580,627,000 | — | 31 Mar 2023 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.3%
|
1,864,745
|
$518,455,005 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.2%
|
1,752,614
|
$487,279,363 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,671,289
|
$464,668,481 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
1,641,748
|
$456,455,194 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,474,178
|
$409,865,453 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
1,416,521
|
$393,801,499 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.94%
|
1,377,534
|
$382,995,778 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.92%
|
1,358,547
|
$377,716,821 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.91%
|
1,333,990
|
$370,889,239 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.89%
|
1,305,851
|
$363,066,271 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.86%
|
1,263,837
|
$351,385,000 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.76%
|
1,114,602
|
$309,892,795 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.75%
|
1,108,366
|
$308,158,999 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.7%
|
1,023,927
|
$284,682,423 | — | 31 Mar 2023 | |
| Beutel, Goodman & Co Ltd. |
13F
|
Company |
0.66%
|
977,726
|
$271,837,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.57%
|
844,382
|
$234,763,604 | — | 31 Mar 2023 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.55%
|
810,378
|
$225,309,000 | — | 31 Mar 2023 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.48%
|
699,269
|
$194,417,760 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.47%
|
695,113
|
$193,262,267 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
661,449
|
$183,902,505 | — | 31 Mar 2023 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.44%
|
643,000
|
$178,773,290 | — | 31 Mar 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
619,798
|
$172,322,438 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.41%
|
606,960
|
$168,753,000 | — | 31 Mar 2023 | |
| Amundi |
13F
|
Individual |
0.39%
|
578,293
|
$164,229,429 | — | 31 Mar 2023 | |
| Alexander J. Denner |
3/4/5
|
Director |
—
class O/S missing
|
658,099
|
$163,208,552 | — | 15 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.39%
|
571,500
|
$158,894,145 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.36%
|
532,933
|
$148,171,360 | — | 31 Mar 2023 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.36%
|
532,892
|
$148,159,963 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
513,392
|
$142,738,000 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.34%
|
505,000
|
$140,405,150 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
485,910
|
$135,097,559 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
457,843
|
$127,294,090 | — | 31 Mar 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.31%
|
450,000
|
$125,113,500 | — | 31 Mar 2023 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.3%
|
441,497
|
$122,749,411 | — | 31 Mar 2023 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.29%
|
429,970
|
$119,084,491 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.29%
|
425,686
|
$118,353,478 | — | 31 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
422,486
|
$117,011,723 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.28%
|
416,004
|
$115,661,592 | — | 31 Mar 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.28%
|
408,912
|
$113,690,000 | — | 31 Mar 2023 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.27%
|
399,090
|
$110,958,993 | — | 31 Mar 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.26%
|
385,592
|
$107,206,112 | — | 31 Mar 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
0.26%
|
381,282
|
$106,007,834 | — | 31 Mar 2023 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q2 2023
As of 30 Jun 2023,
BIOGEN INC. - Common Stock (BIIB) was held by
994 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
126,306,466 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, and Clearbridge Investments, LLC.
This page lists
998
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
987
Q2 2023 holders
994
Holder diff
7
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.